About: Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 1990

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 1990 (uk) im September 1990 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 1990 (ast) scientific article published on 01 September 1990 (en)
publication date	wds:Q68668057-C73CED46-8989-4897-90EB-136BE640E3C5
publication date	1990-09-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q68668057-5A564AC5-229C-4613-878B-E1E77DBDB02B wds:Q68668057-A4891B4E-15C1-4ACE-B84F-9B04BBFC80D1
author name string	Liu CC Kalu DN
rdfs:label	Human parathyroid hormone- (nl) Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats (en)
skos:prefLabel	Human parathyroid hormone- (nl) Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats (en)
name	Human parathyroid hormone- (nl) Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats (en)
title	wds:Q68668057-16B34498-5DED-451E-AC70-F61825E6757A
title	Human parathyroid hormone-(1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats (en)
page(s)	wds:Q68668057-36416E05-A802-4189-AC85-821A60183457
page(s)	973-982
instance of	wds:Q68668057-3BB6CF23-4401-4B38-90A0-F7F8E07641B4
instance of	scholarly article
PubMed ID	wds:Q68668057-E16BEFFC-B630-47F9-8671-C907B59384F5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2281827
PubMed ID	2281827
published in	wds:Q68668057-3B447933-14BC-44CE-A2BB-25373E603835
published in	Journal of Bone and Mineral Research
issue	wds:Q68668057-D16F615E-5629-404F-A841-E107FF50CA1C
volume	wds:Q68668057-0B9A4809-4E6A-4A5B-99A9-EBCC1B45382D
issue	9
volume	5
DOI	wds:Q68668057-91A2EA62-98CE-4A90-BB5D-549F8453B04C
DOI	http://dx.doi.org/10.1002/JBMR.5650050911
DOI	10.1002/JBMR.5650050911
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68668057
is cites work of	Parathyroid hormone treatment improves the cortical bone microstructure by improving the distribution of type I collagen in postmenopausal women with osteoporosis Differential effects of intermittent and continuous administration of parathyroid hormone on bone histomorphometry and gene expression Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). Habitual high phosphorus intakes and foods with phosphate additives negatively affect serum parathyroid hormone concentration: a cross-sectional study on healthy premenopausal women. Experimental model for stimulation of cultured human osteoblast-like cells by high frequency vibration. The ovariectomized rat model of postmenopausal bone loss An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis Pulmonary delivery of drugs for bone disorders Influence of ferutinin on bone metabolism in ovariectomized rats. II: role in recovering osteoporosis. Minocycline prevents the decrease in bone mineral density and trabecular bone in ovariectomized aged rats Effects of cerivastatin and parathyroid hormone on the lumbar vertebra of aging male Sprague-Dawley rats Synthetic parathyroid hormone-like protein (1-74) is anabolic for bone in vivo Bone responses at various skeletal sites to human parathyroid hormone in ovariectomized rats: effects of long-term administration, withdrawal, and readministration Effects of a weekly injection of human parathyroid hormone (1-34) and withdrawal on bone mass, strength, and turnover in mature ovariectomized rats Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo Gene therapy approaches for modulating bone regeneration Early effects of short-term parathyroid hormone administration on bone mass, mineral content, and strength in female rats Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1-34) and 17 beta-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia Effects of reciprocal treatment with estrogen and estrogen plus parathyroid hormone on bone structure and strength in ovariectomized rats Intermittent administration of bovine PTH-(1-34) increases serum 1,25-dihydroxyvitamin D concentrations and spinal bone density in senile (23 month) rats Preexisting bone loss associated with ovariectomy in rats is reversed by parathyroid hormone [Ex-vivo gene therapy with BMP-4 for critically sized defects and enhancement of fracture healing in an osteoporotic animal model] Phosphodiesterase inhibitors, pentoxifylline and rolipram, increase bone mass mainly by promoting bone formation in normal mice Age and ovariectomy impair both the normalization of mechanical properties and the accretion of mineral by the fracture callus in rats Estrogen receptors and biologic response in rat parathyroid tissue and C cells Low calcium:phosphorus ratio in habitual diets affects serum parathyroid hormone concentration and calcium metabolism in healthy women with adequate calcium intake. Histone H4-related osteogenic growth peptide (OGP): a novel circulating stimulator of osteoblastic activity Truncation of the amino terminus of PTH alters its anabolic activity on bone in vivo Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles Prostaglandin E2 increased rat cortical bone mass when administered immediately following ovariectomy Growth hormone increases vertebral and femoral bone strength in osteopenic, ovariectomized, aged rats in a dose-dependent and site-specific manner Advantages of concurrent use of anabolic and antiresorptive agents over single use of these agents in increasing trabecular bone volume, connectivity, and biomechanical competence of rat vertebrae PTH[1-34] improves the effects of core decompression in early-stage steroid-associated osteonecrosis model by enhancing bone repair and revascularization. Ovariectomy-induced bone loss and the hematopoietic system In vivo effects of transforming growth factor-beta 2 in ovariectomized rats Estrogen modulates the mRNA levels for cancellous bone protein of ovariectomized rats Parathyroid hormone and growth hormone have additive or synergetic effect when used as intervention treatment in ovariectomized rats with established osteopenia Properties of a Stable and Sustained-Release Formulation of Recombinant Human Parathyroid Hormone (rhPTH) with Chitosan and Silk Fibroin Microparticles Ovariectomized rat model of osteoporosis: a practical guide Specific evaluation of localized bone mass and bone loss in the rat using dual-energy X-ray absorptiometry subregional analysis Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1-31)NH2 (Ostabolin). Influence of a low calcium and phosphorus diet on the anabolic effect of human parathyroid hormone (1-38) in female rats Decreased cortical and increased cancellous bone in two children with primary hyperparathyroidism Effects of separate and combined therapy with growth hormone and parathyroid hormone on lumbar vertebral bone in aged ovariectomized osteopenic rats Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats Domain-specific gene activation by parathyroid hormone in osteoblastic ROS17/2.8 cells Long-term therapy of ovariectomy-induced osteopenia with parathyroid hormone analog SDZ PTS 893 and bone maintenance in retired breeder rats Bone anabolic effects of separate and combined therapy with growth hormone and parathyroid hormone on femoral neck in aged ovariectomized osteopenic rats Comparison of parathyroid hormone and strontium ranelate in combination with whole-body vibration in a rat model of osteoporosis. Structural changes in condylar cartilage following prolonged exposure to the human parathyroid hormone fragment (hPTH) 1?34 in vitro Amylin increases bone volume but cannot ameliorate diabetic osteopenia Interpretation of bone mass determinations as they relate to fracture: Implications for asymptomatic primary hyperparathyroidism Abaloparatide exhibits greater osteoanabolic response and higher cAMP stimulation and β-arrestin recruitment than teriparatide Comments on "cyclosporin does not affect the absolute rate of cortical bone resorption at the organ level in the growing rat"
is cites work of	wds:Q72342091-4423CF18-8BF1-4DEA-9A23-56503FB402E4 wds:Q89619541-00D6A049-2F84-476B-9EC0-54B8CBC99449 wds:Q34669140-9DA09887-6CB4-4133-AE73-128381E070BB wds:Q35836995-0BFA0A57-FE6C-497F-98CF-852398F9FA6E wds:Q41168746-158E78C8-DEA5-40A7-83E4-CCF2CA55E8E2 wds:Q46289309-0FE1EE12-0327-4C21-A65D-32EAE6BA8440 wds:Q70484056-F5D83D87-B5C6-44CD-B8C8-16FA33A45A3E wds:Q73211266-F8968F00-4162-4813-857A-6316AEDF5FDF

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software